NASDAQ:APTO
Aptose Biosciences Inc.
- Stock
Last Close
0.79
26/07 19:59
Market Cap
18.29M
Beta: 1.73
Volume Today
4.03K
Avg: 169.36K
PE Ratio
−0.27
PFCF: −0.72
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
May '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | |||||||||||
average payables | 644.94K - | 487.14K 24.47% | 188.08K 61.39% | 657.50K - | 1.64M 149.05% | 2.07M 26.14% | 1.94M 6.32% | 4.01M 107.36% | 4.91M 22.34% | ||
average receivables | |||||||||||
book value per share | 75.37 - | 17.15 77.24% | 8.62 49.76% | 6.86 20.41% | 6.33 7.77% | 28.09 344.04% | 21.80 22.40% | 12.50 42.65% | 0.41 96.73% | ||
capex per share | -0.06 - | -0.30 413.84% | -0.00 98.54% | -0.01 99.58% | -0.15 1,591.15% | -0.03 79.36% | -0.01 52.53% | -0.04 146.52% | -0.00 99.27% | ||
capex to depreciation | -1.05 - | -3.44 228.12% | -0.03 99.06% | -0.15 376.67% | -3.78 2,343.50% | -0.17 95.60% | -0.13 22.68% | -0.34 164.90% | -0.05 86.66% | -0.06 36.91% | |
capex to operating cash flow | 0.00 - | 0.03 911.05% | 0.00 98.83% | 0.00 315.15% | 0.01 1,022.25% | 0.00 66.63% | 0.00 50.73% | 0.00 110.02% | 0.00 84.83% | 0.00 12.41% | |
capex to revenue | |||||||||||
cash per share | 80.53 - | 17.93 77.74% | 9.34 47.92% | 7.68 17.72% | 7.07 7.98% | 29.19 312.80% | 22.43 23.14% | 13.32 40.61% | 0.51 96.18% | ||
days of inventory on hand | |||||||||||
days payables outstanding | |||||||||||
days sales outstanding | |||||||||||
debt to assets | 0.02 - | 0.02 - | 0.01 44.21% | 0.01 18.23% | 0.03 267.13% | 0.08 206.02% | |||||
debt to equity | 0.02 - | 0.02 - | 0.01 44.63% | 0.01 14.39% | 0.03 346.51% | -0.35 1,113.41% | |||||
dividend yield | |||||||||||
earnings yield | -0.37 - | -0.34 8.81% | -0.81 137.31% | -0.24 70.94% | -0.45 92.91% | -0.09 80.05% | -0.15 68.15% | -0.53 251.17% | -0.05 90.35% | ||
enterprise value | 8.63M - | 22.60M 161.91% | 9.18M 59.37% | 38.93M 324.04% | 48.30M 24.07% | 205.42M 325.30% | 242.91M 18.25% | 83.49M 65.63% | 759.74M 810.00% | -8.24M 101.08% | |
enterprise value over ebitda | -0.98 - | -1.99 102.32% | -0.67 66.42% | -3.35 401.41% | -1.67 50.28% | -7.83 369.46% | -4.40 43.73% | -1.29 70.75% | -18.06 1,302.35% | ||
ev to operating cash flow | -1.10 - | -2.48 125.77% | -0.75 69.67% | -3.78 403.74% | -2.08 44.98% | -9.53 357.83% | -7.17 24.78% | -1.93 73.10% | -23.51 1,119.19% | 0.18 100.79% | |
ev to sales | |||||||||||
free cash flow per share | -22.68 - | -11.80 47.99% | -14.39 22.02% | -6.93 51.88% | -10.57 52.64% | -6.48 38.74% | -6.23 3.87% | -7.33 17.68% | -0.35 95.22% | ||
free cash flow yield | -0.30 - | -0.30 0.10% | -0.71 135.71% | -0.21 70.91% | -0.37 77.99% | -0.08 79.37% | -0.09 23.87% | -0.36 277.11% | -0.04 88.60% | ||
graham net net | 74.01 - | 15.79 78.67% | 7.79 50.68% | 6.50 16.57% | 5.82 10.45% | 27.23 368.04% | 21.09 22.55% | 11.93 43.44% | 0.36 96.94% | ||
graham number | 217.79 - | 71.59 67.13% | 56.24 21.44% | 34.78 38.16% | 42.96 23.52% | 69.69 62.21% | 70.13 0.63% | 55.59 20.73% | 2.02 96.36% | ||
income quality | 0.81 - | 0.87 7.05% | 0.88 1.88% | 0.88 0.04% | 0.80 8.91% | 0.82 2.05% | 0.61 25.22% | 0.66 8.00% | 0.77 16.63% | 0.87 12.67% | |
intangibles to total assets | 0 - | 0.00 Infinity% | 0.00 8.49% | 0 100% | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -36.80 - | -368.16 900.36% | -281.82 23.45% | 55.32 - | |||||||
interest debt per share | 2.09 - | 0.04 98.13% | 0.06 48.06% | 0.46 - | 0.20 57.03% | 0.10 50.90% | 0.01 94.02% | ||||
inventory turnover | |||||||||||
invested capital | 0.02 - | 0.02 - | 0.01 44.63% | 0.01 14.39% | 0.03 346.51% | -0.35 1,113.41% | |||||
market cap | 25.99M - | 30.89M 18.84% | 17.11M 44.59% | 49.56M 189.60% | 63.60M 28.33% | 283.73M 346.12% | 359.23M 26.61% | 122.03M 66.03% | 795.41M 551.82% | ||
net current asset value | 26.19M - | 13.30M 49.21% | 7.11M 46.56% | 10.06M 41.51% | 13.70M 36.15% | 92.22M 573.26% | 117.73M 27.67% | 73.45M 37.61% | 36.23M 50.67% | -4.00M 111.03% | |
net debt to ebitda | 1.98 - | 0.73 63.12% | 0.58 20.91% | 0.92 58.47% | 0.53 42.33% | 2.98 465.02% | 2.11 29.32% | 0.59 71.81% | 0.85 42.62% | ||
net income per share | -27.97 - | -13.28 52.52% | -16.31 22.85% | -7.84 51.95% | -12.97 65.43% | -7.68 40.74% | -10.03 30.49% | -10.99 9.58% | -0.44 95.95% | ||
operating cash flow per share | -22.62 - | -11.50 49.18% | -14.39 25.16% | -6.92 51.93% | -10.43 50.69% | -6.45 38.16% | -6.21 3.64% | -7.29 17.38% | -0.35 95.20% | ||
payables turnover | |||||||||||
receivables turnover | |||||||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | -0.34 - | -0.69 102.17% | -1.61 133.03% | -0.97 39.44% | -1.71 75.61% | -0.26 85.05% | -0.43 69.42% | -0.79 82.51% | -0.80 1.74% | ||
revenue per share | |||||||||||
roe | -0.37 - | -0.77 108.62% | -1.89 144.52% | -1.14 39.62% | -2.05 79.36% | -0.27 86.66% | -0.46 68.16% | -0.88 91.08% | -1.09 23.73% | ||
roic | -0.35 - | -0.77 117.52% | -1.89 145.78% | -1.14 39.41% | -2.05 79.37% | -0.27 86.79% | -0.46 68.47% | -0.87 89.99% | -1.04 19.53% | ||
sales general and administrative to revenue | |||||||||||
shareholders equity per share | 75.37 - | 17.15 77.24% | 8.62 49.76% | 6.86 20.41% | 6.33 7.77% | 28.09 344.04% | 21.80 22.40% | 12.50 42.65% | 0.41 96.73% | ||
stock based compensation to revenue | |||||||||||
tangible asset value | 26.21M - | 13.57M 48.24% | 7.30M 46.22% | 10.20M 39.82% | 14.08M 38.02% | 93.93M 567.04% | 118.92M 26.60% | 74.24M 37.57% | 37.74M 49.16% | -2.90M 107.69% | |
tangible book value per share | 75.37 - | 17.09 77.32% | 8.59 49.75% | 6.86 20.15% | 6.33 7.77% | 28.09 344.04% | 21.80 22.40% | 12.50 42.65% | 0.41 96.73% | ||
working capital | 26.68M - | 13.30M 50.14% | 7.11M 46.56% | 10.06M 41.51% | 13.70M 36.15% | 93.23M 580.64% | 118.26M 26.86% | 73.56M 37.80% | 37.23M 49.38% | -3.38M 109.06% |
All numbers in USD (except ratios and percentages)